Sino Biopharmaceutical Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SMZ1.SG | X2S.F | S1R.F | 002294.SZ | CVG.F | 603858.SS | |
|---|---|---|---|---|---|---|
| Market cap | — | 5.94B | 4.64B | 35.23B | 10.81B | 15.95B |
| P/E (TTM) | 19.5 | 6.8 | 7.4 | 49.4 | 11.8 | 54.0 |
| Forward P/E | — | — | — | 49.4 | — | — |
| Price/book | 2.6 | 0.5 | 0.4 | 4.0 | 2.2 | 1.6 |
| Dividend yield | 2.21% | 4.63% | 4.67% | 1.75% | 4.75% | 3.67% |
| 1-year change | +92.36% | −12.64% | −3.85% | −45.45% | +10.47% | −9.81% |
| Today | +9.58% | −0.88% | 0.00% | +0.32% | +3.60% | +0.40% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All SMZ1.SG news ›Sino Biopharmaceutical, Boehringer ink cancer drug deal worth $7 billion in milestones
• The Chinese drugmaker will receive $358 million in upfront and near-term payments under the deal, it said • The deal covers six preclinical cancer programs spanning antibody-drug conjugates, which use antibodies to deliver toxic drugs…
Sino Biopharmaceutical Enters Partnership With Boehringer Ingelheim With Potential Deal Value Of $7 Bln
TradingView Sino Biopharmaceutical Enters Partnership With Boehringer Ingelheim With Potential Deal Value Of $7 Bln
STADA and Sino Biopharmaceutical Enter into Exclusive Partnership for up to Four Biosimilars, Including to MSD’s Keytruda® (Pembrolizumab)
Home / News / BioBlast® On 28 September 2026, STADA announced that it has entered into an exclusive partnership with Chia Tai Tianqing Pharmaceutical Group (CTTQ), a subsidiary of Sino Biopharmaceutical Limited, for up to four biosimilars.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- freedom959.net1
- pearceip.law1
- pharmexec.com1
- srnnews.com1
- tradingview.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.